Faculty Position: Head and Neck Cancer Research Scientist

** Responsibilities*
* ** Position Description*
* The Department of Otolaryngology - Head and Neck Surgery at Mayo Clinic and Mayo Clinic Comprehensive Cancer Center are seeking an exceptional scientific investigator engaged in discovery and translational sciences in cancers of the head and neck. The ideal candidate will be an outstanding scholar with a record of exceptional achievement and demonstrated ability to drive discovery to translational science, and through collaboration, to clinical interventions in head and neck cancers.

The ideal candidate will be a mid-career basic/translational scientist with a track record of substantial scientific accomplishments.

To achieve the overall goal of the Head and Neck Disease Group (DG) of Mayo Clinic Comprehensive Cancer Center to translate innovative discoveries to clinical interventions in our patients through advanced clinical trials, we are seeking a translational scientist with expertise in biomarkers of Head and Neck cancer/pre-cancer, immuno-oncology, cellular engineering in head and neck cancer, genetics, virology, and/or cancer vaccine development.

We seek to identify mid-career investigators who collaborate with our DG multi-disciplinary team; serve as a mentor to promote junior faculty development, grant writing, and program development; and lead the expansion and development of scientific program in head and neck cancers at Mayo Clinic. The position is accompanied by leadership opportunities and an endowed Chair.

** Why Choose Mayo Clinic Comprehensive Cancer Center?*
* With 440 members and 1500 aligned cancer physicians working in six Cancer Research Programs  _(Cancer Prevention, Survivorship & Control;
Cancer Risk Assessment, Early Detection & Interception;
Cancer Genomics, Signaling, & Metastasis;
Cancer Immunology & Immunotherapeutics; Novel Therapeutics & Therapeutic Modalities; Advanced Clinical Trials and Translational Sciences)_  and 15 Disease Groups focused on clinical trials, MCCCC is a global leader and represents the pinnacle of cancer care, research and education and training. Every year, across its three enterprise sites (Rochester, Minnesota; Phoenix and Scottsdale, Arizona; and Jacksonville, Florida), MCCCC physicians provide expert cancer diagnosis and treatment to more than 150,000 unique patients from across the nation and the globe.

MCCCC created one of the nation's first National Cancer Institute (NCI)-Designated Cancer Center Research Programs focused on early cancer detection and interception:  _Cancer Risk Assessment, Early Detection, and Interception (REDI). The Center's other five transdisciplinary research programs include Cancer Prevention, Control, and Survivorship;
Cancer Genomics, Signaling, and Metastasis;
Cancer Immunology and Immunotherapeutics;
Novel Therapeutics and Therapeutic Modalities; and Advanced Clinical Trials and Translational Research._

** The MCCCC Mission:
** To inspire hope and promote health and healing through integrated research, clinical practice, and education, centered around our primary value:  
** the needs of the patient come first.*
* ** The MCCCC Vision:
** To be a global cancer authority: transforming cancer research and practice to assure that our discoveries, knowledge, and expertise are accessible to all, within and beyond our walls, at anyplace and anytime.

** MCCCC Goals:*
* 1. To cure cancers through translation of innovative transdisciplinary science to new means of prevention, early detection, interception, intervention, and unparalleled care delivery.

2. To transform cancer research and practice using category of one data platforms, digital technologies, artificial intelligence (AI), and intelligent automation, creating new models for community and patient engagement, and the conduct of research, clinical trials and patient-centered care delivery in clinical, home, and community settings.

3. To use Mayo Clinic Platform to engage patients and communities in our catchment areas and across the nation and the world in cancer research and distributed and decentralized clinical trials.

4. To educate, train, and mentor the next generation of cancer physicians, scientists, and…